Inscription Capital’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$113K Buy
11,540
+1,060
+10% +$10.5K 0.01% 767
2026
Q1
$102K Sell
10,480
-172
-2% -$1.58K 0.01% 681
2025
Q4
$102K Buy
10,652
+172
+2% +$1.75K 0.01% 656
2025
Q3
$102K Buy
+10,480
New +$80.6K 0.01% 609

Other funds holding PRTA

Inscription Capital's PRTA Position: Q2 2026 in Review

Inscription Capital increased its Prothena Corp (PRTA) stake by 10% in Q2 2026, buying an estimated $10.5K and bringing the position to 11,540 shares worth $113K. The position accounts for 0.01% of the portfolio, ranked #767.

Inscription Capital first reported a position in PRTA in Q3 2025 and has held it in 4 quarters since. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Inscription Capital held 11,540 shares of Prothena Corp worth $113K as of Q2 2026.
  • Inscription Capital bought 1,060 Prothena Corp shares in Q2 2026, an estimated $10.5K.
  • Prothena Corp made up 0.01% of Inscription Capital's portfolio in Q2 2026, its #767 holding.
  • Inscription Capital first reported a position in Prothena Corp in Q3 2025 and has held it in 4 quarters since.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.